Dergiler / Haydarpaşa Numune Medical Journal / 2019 / Cilt: 59 - Sayı: 2

The Effect of Bilirubin Levels on Results of Auditory Screening in Newborns

Sayfa
123–127
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

However, the clinician should consider that the neonatal jaundice is a risk factor for hearing loss.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Introduction: To evaluate the effect of bilirubin levels on auditory screening results in newborns.
📊
Temel Bulgular & Veri:Methods: In total, 43 newborns (24 males and 19 females) who underwent the neonatal auditory screening in our hospital were included in the present study.
💡
Sonuç & Katkı:However, the clinician should consider that the neonatal jaundice is a risk factor for hearing loss.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Introduction: To evaluate the effect of bilirubin levels on auditory screening results in newborns. Methods: In total, 43 newborns (24 males and 19 females) who underwent the neonatal auditory screening in our hospital were included in the present study. All newborns were evaluated before they were discharged from the hospital. They were divided into two groups according to the results of the screening. Group A consisted of newborns that cleared the screening, whereas group B consisted of the remaining cases. Results: There were 31 newborns (16 males, 15 females) in group A and 12 newborns (8 males, 4 females) in group B. In group A, mean total serum bilirubin level was 24.7±8.1 mg/dl, mean serum indirect bilirubin level was 23.3±8.0 mg/dl and mean serum direct bilirubin level was 1.1±1.6 mg/dl. In group B, these values were 28.1±6.6 mg/dL, 27.1±6.4 mg/dL, and 1.4±1.3 mg/dL, respectively. There were no statistically significant between-group differences between total serum bilirubin levels, indirect, and direct serum bilirubin levels (p-values: 0.279, 0.168, and 0.233, respectively). There was no significant difference between hematocrit, reticulocyte, leukocyte, and platelet values of the groups (all p-values >0.05). Discussion and Conclusion: The results of the newborn auditory screening were not affected by serum bilirubin levels. However, the clinician should consider that the neonatal jaundice is a risk factor for hearing loss.

🔖

Bu Makaleye Atıf Yap

ALTINTAŞ, A., ÇELİK, M., KOÇ, A. K., SARI, E., SALİHOĞLU, Ö. (2019). The Effect of Bilirubin Levels on Results of Auditory Screening in Newborns. Haydarpaşa Numune Medical Journal, Cilt: 59 - Sayı: 2, 123–127. https://ajindex.com/articles/209719

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Okhravi T, Tarvij Eslami S, Hushyar Ahmadi A, Nassirian H, Najibpour R. Evaluation of auditory brain stems evoked response in newborns with pathologic hyperbilirubinemia in mashhad, iran. Iran Red Crescent Med J 2015
  2. e18288. [CrossRef ] 2. Soni A, Kanaujia SK, Kaushik S. Brainstem Evoked Response Audiometry (BERA) in Neonates with Hyperbillirubinemia. Indian J Otolaryngol Head Neck Surg 2016
  3. 334–8. [CrossRef ] 3. Akinpelu OV, Waissbluth S, Daniel SJ. Auditory risk of hyperbilirubinemia in term newborns: a systematic review. Int J Pediatr Otorhinolaryngol 2013
  4. 898–905. [CrossRef ] 4. Corujo-Santana C, Falcón-González JC, Borkoski-Barreiro SA, Pérez-Plasencia D, Ramos-Macías Á. The relationship between neonatal hyperbilirubinemia and sensorineural hearing loss. [Article in English, Spanish]. Acta Otorrinolaringol Esp 2015
  5. 326–31. [CrossRef ] 5. Amin SB, Saluja S, Saili A, Orlando M, Wang H, Laroia N, et al. Chronic Auditory Toxicity in Late Preterm and Term Infants With SignificantHyperbilirubinemia. Pediatrics 2017
  6. 140(4). 6. Sezer HÖ, Topal K, Aksoy H, Gereklioğlu Ç, Çelik Ü,Yıldırım İ. İşitme tarama ünitesine başvuran bebeklerde işitme kaybı için risk faktörlerinin belirlenmesi ve işitme tarama testleri sonuçlarına etkisinin araştırılması. Mustafa Kemal Üniv Tıp Derg 2017
  7. 19–26. [CrossRef ] 7. Alkalay AL, Simmons CF. Hyperbilirubinemia guidelines in newborn infants. Pediatrics 2005
  8. 824–5. [CrossRef ] 8. Bhutani VK, Maisels MJ, Stark AR, Buonocore G
  9. Expert Committee for Severe Neonatal Hyperbilirubinemia
  10. European Society for Pediatric Research
  11. American Academy of Pediatrics. Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants >or=35 weeks gestation. Neonatology 2008
  12. 63–7. [CrossRef ] 9. Schwartz HP, Haberman BE, Ruddy RM. Hyperbilirubinemia: current guidelines and emerging therapies. Pediatr Emerg Care 2011
  13. 884–9. [CrossRef ] 10. Boo NY, Oakes M, Lye MS, Said H. Risk factors associated with hearing loss in term neonates with hyperbilirubinaemia. J Trop Pediatr 1994
  14. 194–7. [CrossRef ] 11. Sheykholeslami K, Kaga K. Otoacoustic emissions and auditory brainstem responses after neonatal hyperbilirubinemia. Int J Pediatr Otorhinolaryngol 2000
  15. 65–73. [CrossRef ] 12. Shaia WT, Shapiro SM, Spencer RF. The jaundiced gunn rat model of auditory neuropathy/dyssynchrony. Laryngoscope 2005
  16. 2167–73. [CrossRef ] 13. Haustein MD, Read DJ, Steinert JR, Pilati N, Dinsdale D, Forsythe ID. Acute hyperbil